Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Genmab Director's Dealing 2020

Jan 28, 2020

3365_rpt_2020-01-28_4a105c96-351b-4047-b632-797526d970d4.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1. Details of the person discharging managerial responsibilities /
person closely associated
a) Name Paolo Paoletti
2. Reason for the notification
a) Position/status Member of the Board of Directors
b) Initial notification/Amendment Amendment (the content of this amendment is similar to the
notification of December 20, 2019 (ID 116949) but is reported
as a different announcement type)
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Genmab A/S
b) LEI-code 529900MTJPDPE4MHJ122
4. Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial Share
instrument, type of instrument
Identification code DK0010272202
b) Nature of the transaction Sale of shares
c) Price(s) and volume(s) Price(s) Volume(s)
DKK 1,469.00 86
DKK 1,469.50 283
DKK 1,470.00 109
d) Aggregated information
- Aggregated volume
478 shares
- Price DKK 1,469.52
e) Date of the transaction 2019-12-20
f) Place of the transaction Aquis Exchange (AQXE)
CBOE Europe (BATE and CHIX)
Nasdaq Copenhagen (XCSE)
1. Details of the person discharging managerial responsibilities /
a) person closely associated
Name
Peter Storm Kristensen
2. Reason for the notification
a) Position/status Member of the Board of Directors
b) Initial notification/Amendment Amendment (the content of this amendment is similar to the
notification of December 20, 2019 (ID 116949) but is reported
as a different announcement type)
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Genmab A/S
b) LEI-code 529900MTJPDPE4MHJ122
4. Details of the transaction(s): section to be repeated for (iii) each date; and (iv) each place where transactions have been conducted
(i) each type of instrument; (ii) each type of transaction;
a)
Description of the financial
Share
instrument, type of instrument
Identification code DK0010272202
b) Nature of the transaction Sale of shares
c) Price(s) and volume(s) Price(s) Volume(s)
DKK 1,465.00 300
d) Aggregated information
- Aggregated volume
- Price
e) Date of the transaction 2019-12-20
f) Place of the transaction Nasdaq Copenhagen (XCSE)